Evidence map›Paper›PMID 40377335›Full record

ArticlemSphere2025

Highlights of the 14th International

Kevin Munoz Navarrete, Kathryn M Edwards, Kingston H G Mills, Jana Kamanová, María Eugenia Rodriguez, Andrew Gorringe, Andrew Preston, Beate Kampmann, Monica C Gestal, Eric T Harvill and 6 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kevin Munoz NavarreteInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0009-0007-2827-9102
Kathryn M EdwardsDivision of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kingston H G MillsSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Leinster, Ireland.
Jana KamanováInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0000-0001-6574-4404
María Eugenia RodriguezCINDEFI (UNLP, CONICET La Plata), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Buenos Aires Province, Argentina.
Andrew GorringeUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Andrew PrestonThe Milner Centre for Evolution and Department of Life Sciences, University of Bath, Bath, United Kingdom.
Beate KampmannClinical Research, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Monica C GestalDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, Louisiana, USA.
Eric T HarvillDepartment of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, Georgia, USA.
Purnima DubeyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Dimitri A DiavatopoulosLaboratory of Medical Immunology, Radboud Community of Infectious Diseases, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Gelderland, Netherlands.
Seema MattooDepartments of Biological Sciences and Biochemistry, Purdue University, West Lafayette, Indiana, USA.
Karen M ScanlonDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Camille LochtUniversité Lille, Centre National de la Recherche Scientifique, Inserm, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1019 Unité Mixte de Recherche 8204, Center for Infection and Immunity of Lille, Lille, France.
Peter SeboInstitute of Microbiology of the Czech Academy of Sciences, Prague, Czechia.ORCID 0000-0002-9755-7715

Funding

An air-liquid interface system to study Bordetella pertussis interactions with respiratory epitheliaR21AI171346 · NIAID · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2023 to 2024
$410k
Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussisR21AI182884 · NIAID · UNIVERSITY OF GEORGIA · PI Eric T Harvill · 2025 to 2026
$393k
14th International Bordetella SymposiumR13AI183722 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI GESTAL, MONICA CARTELLE, SCANLON, KAREN · 2024 to 2024
$7k
Institute of Microbiology of the Czech Academy of Sciences RVO61388971Ministerstvo Školství, Mládeže a Tělovýchovy LX22NPO5103, LM2023053, CZ.02.01.01/00/22_008/0004597National Institute of Allergy and Infectious Diseases 1R13AI183722-01, R13AI183722NIAID NIH HHS R13 AI183722NIAID NIH HHS R21 AI171346NIAID NIH HHS R21 AI182884
6 · The paper itself

Abstract

Pertussis, or whooping cough, is a highly contagious and acute respiratory illness caused primarily by the gram-negative coccobacillus

Indexed as

Bordetella pertussisWhooping CoughFemaleGlobal HealthHumansInfant, NewbornPertussis VaccinePregnancyVaccinationPertussis VaccineBordetella pertussisepidemiologypathogenesistoxinsvaccinesvirulence

Identifiers

PMID40377335
PMCPMC12188742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.